CASC2 inhibits the expression of miR-18a-5p by acting as a molecular sponge for miR-18a-5p, positively regulates the expression of BTG3, and thereby achieves the suppression of CRC cell proliferation (78). Here, CASC2 is linked to colorectal carcinoma.